We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-15.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$163B
AUM Growth
+$35.8B
Cap. Flow
+$63.1B
Cap. Flow %
38.57%
Top 10 Hldgs %
39.01%
Holding
5,544
New
560
Increased
1,332
Reduced
2,502
Closed
413

Sector Composition

Rank Sector Weight
1 Technology 12.9%
2 Financials 7.33%
3 Healthcare 6.04%
4 Consumer Discretionary 5.46%
5 Communication Services 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCTR icon
4226
Victory Capital Holdings
VCTR
$6.65B
$20K ﹤0.01%
828
-1,166
-58% -$31.4K
VSEC icon
4227
VSE Corp
VSEC
$6.12B
$20K ﹤0.01%
532
-1,189
-69% -$46.6K
WTBA icon
4228
West Bancorporation
WTBA
$485M
$20K ﹤0.01%
813
-1,798
-69% -$44.8K
YALA
4229
Yalla Group
YALA
$832M
$20K ﹤0.01%
5,000
TECX
4230
Tectonic Therapeutic
TECX
$606M
$20K ﹤0.01%
1,828
-3,278
-64% -$38.6K
SPRB
4231
Spruce Biosciences
SPRB
$129M
$20K ﹤0.01%
153
-16
-9% -$2.05K
SLAC
4232
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
$20K ﹤0.01%
2,083
ACB
4233
Aurora Cannabis
ACB
$185M
$19K ﹤0.01%
1,510
-4,215
-74% -$106K
ACHR icon
4234
Archer Aviation
ACHR
$4.26B
$19K ﹤0.01%
6,299
+6,249
+12,498% +$25.2K
BW icon
4235
Babcock & Wilcox
BW
$1.39B
$19K ﹤0.01%
3,088
-6,062
-66% -$42.4K
CRESY
4236
Cresud
CRESY
$773M
$19K ﹤0.01%
3,900
EE icon
4237
Excelerate Energy
EE
$1.11B
$19K ﹤0.01%
+931
New +$23.6K
EWO icon
4238
iShares MSCI Austria ETF
EWO
$185M
$19K ﹤0.01%
1,044
INO icon
4239
Inovio Pharmaceuticals
INO
$69M
$19K ﹤0.01%
919
-2,030
-69% -$57.2K
KALV
4240
DELISTED
KalVista Pharmaceuticals
KALV
$19K ﹤0.01%
1,970
-1,668
-46% -$18.4K
LOVE
4241
LoveSac
LOVE
$261M
$19K ﹤0.01%
700
-1,440
-67% -$56K
MCFT icon
4242
MasterCraft Boat Holdings
MCFT
$590M
$19K ﹤0.01%
917
-2,066
-69% -$48K
MCBS icon
4243
MetroCity Bankshares
MCBS
$1.03B
$19K ﹤0.01%
937
-2,148
-70% -$44.5K
MLNK
4244
DELISTED
MeridianLink
MLNK
$19K ﹤0.01%
1,153
-2,621
-69% -$45.1K
PMTS icon
4245
CPI Card Group
PMTS
$320M
$19K ﹤0.01%
1,126
REVG
4246
DELISTED
REV Group
REVG
$19K ﹤0.01%
1,749
-4,095
-70% -$48.5K
NTCO
4247
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$19K ﹤0.01%
3,600
-9
-0.2% -$69
ITAQW
4248
DELISTED
Industrial Tech Acquisitions II, Inc. Warrants
ITAQW
$19K ﹤0.01%
+125,000
New +$24.9K
CVT
4249
DELISTED
Cvent Holding Corp. Common Stock
CVT
$19K ﹤0.01%
+4,219
New +$24.6K
CTAQ
4250
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
$19K ﹤0.01%
1,900
-19,572
-91% -$193K

Similar funds

Barclays's Q2 2022 Portfolio in Review

As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.

  • Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
  • Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
  • Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
  • Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
  • Barclays opened 560 new positions and closed 413 in Q2 2022.
  • Barclays's portfolio value rose 28% quarter-over-quarter to $163B.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.